Biotech | May 09, 2022
ExoCoBio receives Japanese patent for alleviating dermatitis
To lay a technological foundation for developing exosome-based medicines and cosmetic products for dermatitis treatment
To lay a technological foundation for developing exosome-based medicines and cosmetic products for dermatitis treatment
The Blockchain-based solution was awarded the 2021 Bionow Technical Service Award
Vortioxetine is a novel antidepressant with multimodal activity, which is approved to treat Major Depressive Disorder (MDD) in adults
The drug is to be supplied in 105 low and middle-income countries and 10 Indian firms are on the list
This agreement allows Natco to expand access to Covid-19 medicines in 105 countries in generic name
They will commercialize molnupiravir in the international markets
Decisions reaffirm the ability of Biocon Biologics and Viatris to provide patient access to interchangeable Semglee
The software enables real-time communication between patients, caregivers, physicians, and pharmacists and each cartridge in the device has a unique, traceable serial number registered to the patient
Celgene will grant Sun Pharma a license to Celgene’s patents required to manufacture and sell certain generic lenalidomide capsules
Tiger can no longer make an important biotin intermediate using a DSM patented process.
Subscribe To Our Newsletter & Stay Updated
